CHU Henri Mondor — Créteil

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Créteil →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of CHU Henri Mondor, compiled from the ClinicalTrials.gov public registry.

215

Registered studies

55

Active

32

Recruiting now

117

Completed

18

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Diffuse Large B Cell Lymphoma · Relapsed Angioimmunoblastic T-Cell Lymphoma · Advanced Renal Cell Carcinoma

Recently updated registry entries

NCT07609108 — Pridopidine Phase 3 Study in Huntington's Disease (Recruiting)
NCT05006716 — A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell… (Recruiting)
NCT05063565 — TheraSphere With Durvalumab and Tremelimumab for HCC (Active Not Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.